leukemia

New diagnostic test for rare leukemia to give faster results

harminka — Mon, 06 Oct 2008 12:03:11 -0500

A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukemias in hours instead of weeks, according to a study by researchers at the Stanford University School of Medicine and UC-San Francisco.

Methadone breaks resistance in untreatable forms of leukemia

harminka — Fri, 01 Aug 2008 08:04:45 -0500

Researchers in Germany have discovered that methadone, an agent used to break addiction to opioid drugs, has surprising killing power against leukemia cells, including treatment resistant forms of the cancer.

Sparing leukemia Patients from unnecessary treatment

harminka — Wed, 30 Jul 2008 01:26:22 -0500

Nearly a third of leukemia patients do not respond to chemotherapy, but this is not usually discovered until they have already endured a week-long chemotherapy treatment and waited a month to see whether it has worked. A new study shows that PET scans could tell how well a patient is responding after just one day of chemotherapy.

Tumor-inhibiting protein could be effective in treating leukemia

harminka — Tue, 15 Jul 2008 08:33:34 -0500

Angiocidin, a tumor-inhibiting novel protein discovered by Temple University researchers, may also have a role as a new therapeutic application in treating leukemia, according to a study by the researchers.

Math could help cure leukemia

harminka — Fri, 20 Jun 2008 07:12:20 -0500

When kids complain that math homework won't help them in real life, a new answer might be that math could help cure cancer.

Combining math and medicine to treat leukemia

harminka — Fri, 20 Jun 2008 01:08:17 -0500

Researchers have produced a mathematical model that may lead to the development of an optimally-timed vaccine for chronic myelogenous leukemia (CML).

Gene mutation improves leukemia drug's effect

harminka — Wed, 18 Jun 2008 08:40:25 -0500

Gene mutations that make cells cancerous can sometimes also make them more sensitive to chemotherapy. A new study led by cancer researchers at Ohio State University shows that a mutation present in some cases of acute leukemia makes the disease more susceptible to high doses of a particular anticancer drug.

Microenvironment main driver of aggressive multi-lineage leukemia disease type

harminka — Tue, 10 Jun 2008 14:18:34 -0500

Research led by scientists at Cincinnati Children's Hospital Medical Center has revealed new clues into what causes different types of a particularly aggressive group of blood cancers known as mixed lineage leukemias (MLL) and how the disease might be treated, according to a study in the June 9 issue of Cancer Cell.

Galiximab with rituximab in patients with previously untreated follicular lymphoma

harminka — Mon, 09 Jun 2008 11:44:16 -0500

The Cancer and Leukemia Group B (CALGB) today announced data from a phase II clinical trial showing that 70 percent of patients with previously untreated follicular lymphoma responded to treatment with galiximab, an investigational anti-CD80 monoclonal antibody, when given in combination with rituximab.

Biological and clinical activity in relapsed leukemia patients

harminka — Thu, 05 Jun 2008 00:50:38 -0500

Finbarr Cotter, M.D., Ph.D., Professor of the Institute of Cell and Molecular Science at Barts and The London School of Medicine, today presented in an oral session "Clinical Caspase Activation in CLL by GCS-100: a Phase 2 Study" at the 10th International Conference on Malignant Lymphoma (10-ICML).

Arsenic-based therapy shown to help eradicate leukemia-initiating cells

harminka — Mon, 12 May 2008 11:22:43 -0500

In both leukemia and solid tumors, there exists among the multitude of warrior cancer cells a small subgroup that work undercover, patiently lying in wait to launch their attacks. Known as either cancer initiating cells (CICs) or leukemia initiating cells (LICs), these stealth populations are impervious to conventional chemotherapy and undaunted by targeted cancer therapies.

Researchers demonstrate safety of gene therapy using adult stem cells

harminka — Thu, 08 May 2008 00:34:03 -0500

A new study by UC Davis researchers provides evidence that methods using human bone marrow-derived stem cells to deliver gene therapy to cure diseases of the blood, bone marrow and certain types of cancer do not cause the development of tumors or leukemia. The study was published online in the May 6, 2008 issue of Molecular Therapy.